Terns Pharmaceuticals
Foster City
About Terns Pharmaceuticals
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer. The company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in China to advance its growing pipeline of drugs that are optimized against clinically-validated targets. Based in San Mateo, California and Shanghai, Terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in China and globally.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Total funding: $1.1B
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: nasdaq:TERN
- Website: ternspharma.com
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/terns-pharmaceuticals-114261 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.